Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
ABL1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 345.0 | Evidence | |||||
ABL1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
ABL1 | CRKL | CRKL: Crk-like protein | 275.0 | Evidence | |||||
ABL1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 258.0 | Evidence | |||||
ABL1 | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 221.0 | Evidence | |||||
ABL1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 206.0 | Evidence | |||||
ABL1 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 206.0 | Evidence | |||||
ABL1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 206.0 | Evidence | |||||
ABL1 | INSR | INSR: Insulin receptor precursor | 147.0 | Evidence | |||||
ABL1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 143.0 | Evidence | |||||
ABL1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 137.0 | Evidence | |||||
ABL1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 137.0 | Evidence | |||||
ABL1 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence | |||||
ABL1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 135.0 | Evidence | |||||
ABL1 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 135.0 | Evidence | |||||
ABL1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 125.0 | Evidence | |||||
ABL1 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence | |||||
ABL1 | STAT3 | 119.0 | Evidence | ||||||
ABL1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence | |||||
ABL1 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence | |||||
ABL1 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 119.0 | Evidence | |||||
ABL1 | SYK | SYK: Tyrosine-protein kinase SYK | 116.0 | Evidence | |||||
ABL1 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 109.0 | Evidence | |||||
ABL1 | CSK | CSK: Tyrosine-protein kinase CSK | 109.0 | Evidence | |||||
ABL1 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 109.0 | Evidence | |||||
ABL1 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 109.0 | Evidence | |||||
ABL1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 109.0 | Evidence | |||||
ABL1 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 109.0 | Evidence | |||||
ABL1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 107.0 | Evidence | |||||
ABL1 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 102.0 | Evidence | |||||
ABL1 | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 101.0 | Evidence | |||||
ABL1 | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 101.0 | Evidence | |||||
ABL1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 89.30 | Evidence | |||||
ABL1 | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 89.20 | Evidence | |||||
ABL1 | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 89.20 | Evidence | |||||
ABL1 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 89.20 | Evidence | |||||
ABL1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 88.80 | Evidence | |||||
ABL1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 88.80 | Evidence | |||||
ABL1 | LYN | LYN: Tyrosine-protein kinase Lyn | 88.80 | Evidence | |||||
ABL1 | APS | SH2B2, APS: SH2B adapter protein 2 | 88.80 | Evidence | |||||
ABL1 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 88.80 | Evidence | |||||
ABL1 | HCK | N/A | 78.20 | Evidence | |||||
ABL1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 70.50 | Evidence | |||||
ABL1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 66.50 | Evidence | |||||
ABL1 | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 66.50 | Evidence | |||||
ABL1 | MET | MET: Hepatocyte growth factor receptor precursor | 58.60 | Evidence | |||||
ABL1 | GRB10 | N/A | 56.20 | Evidence | |||||
ABL1 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 35.30 | Evidence | |||||
ABL1 | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 24.10 | Evidence | |||||
ABL1 | CTTN | CTTN, EMS1: Src substrate cortactin | 22.80 | Evidence | |||||
ABL1 | CD2AP | CD2AP: CD2-associated protein | 22.80 | Evidence | |||||
ABL1 | GRAP | GRAP: GRB2-related adapter protein | 20.70 | Evidence | |||||
ABL1 | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 17.90 | Evidence | |||||
ABL1 | DOK1 | DOK1: Docking protein 1 | 17.30 | Evidence | |||||
ABL1 | WASPIP | N/A | 17.10 | Evidence | |||||
ABL1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 17.10 | Evidence | |||||
ABL1 | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 15.00 | Evidence | |||||
ABL1 | STAM2 | STAM2: Signal transducing adapter molecule 2 | 14.70 | Evidence | |||||
ABL1 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 14.70 | Evidence | |||||
ABL1 | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 14.20 | Evidence | |||||
ABL1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.10 | Evidence | |||||
ABL1 | EFNB2 | EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor | 11.70 | Evidence | |||||
ABL1 | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 11.20 | Evidence | |||||
ABL1 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence | |||||
ABL1 | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 9.71 | Evidence | |||||
ABL1 | SOS1 | SOS1: Son of sevenless homolog 1 | 9.14 | Evidence | |||||
ABL1 | DAB1 | DAB1: Disabled homolog 1 | 8.92 | Evidence | |||||
ABL1 | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 7.40 | Evidence | |||||
ABL1 | KPNB1 | KPNB1, NTF97: Importin subunit beta-1 | 7.20 | Evidence | |||||
ABL1 | EPOR | EPOR: Erythropoietin receptor precursor | 6.52 | Evidence | |||||
ABL1 | EFNB1 | EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor | 6.27 | Evidence | |||||
ABL1 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 6.14 | Evidence | |||||
ABL1 | MCM3 | MCM3: DNA replication licensing factor MCM3 | 5.51 | Evidence | |||||
ABL1 | RANBP1 | RANBP1: Ran-specific GTPase-activating protein | 4.84 | Evidence | |||||
ABL1 | CSE1L | CSE1L, CAS, XPO2: Exportin-2 | 4.48 | Evidence | |||||
ABL1 | XPO1 | XPO1, CRM1: Exportin-1 | 4.48 | Evidence | |||||
ABL1 | PTPN11 | N/A | 3.87 | Evidence | |||||
ABL1 | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 3.87 | Evidence | |||||
ABL1 | RAB5B | RAB5B: Ras-related protein Rab-5B | 3.34 | Evidence | |||||
ABL1 | BCR | N/A | 2.54 | Evidence | |||||
ABL1 | RANBP3 | RANBP3: Ran-binding protein 3 | 2.43 | Evidence | |||||
ABL1 | CDC6 | CDC6, CDC18L: Cell division control protein 6 homolog | 1.50 | Evidence | |||||
ABL1 | NUP153 | N/A | 1.50 | Evidence | |||||
ABL1 | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 1.29 | Evidence | |||||
ABL1 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 1.13 | Evidence | |||||
ABL1 | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
ABL1 | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 1.13 | Evidence | |||||
ABL1 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 1.13 | Evidence | |||||
ABL1 | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
ABL1 | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 1.04 | Evidence | |||||
ABL1 | PLCG1 | PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | 1.04 | Evidence |